Patient Care and Research

AUA/ASTRO/SUO Guideline on Clinically Localized Prostate Cancer

Published: April 2017

Read Executive Summary
Read Full-Text Guideline

This collaborative guideline focuses on the following four topics: 1) shared decision making between physicians and patients with localized prostate cancer; 2) care options based on cancer severity/risk group, from very low risk to high risk; 3) it evaluates a variety of treatment options in this setting, including active surveillance, prostatectomy, radiation therapy, cryosurgery and high-intensity focused ultrasound and focal therapy; and 4) discusses side effects, health-related quality of life, and follow-up for patients treated for localized prostate tumors. 

Developed in collaboration with:

  • American Society for Radiation Oncology
  • American Urological Association
  • Society of Urologic Oncology

Key Points:

  • Shared decision making
  • Treatment options based on disease severity and risk group
  • Active surveillance
  • Radical prostatectomy
  • High-intensity focused ultrasound
  • Focal therapy

Resources:
 

Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer (CME)
Patient Brochure

 

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.